This study investigates pancreatic, lung, breast, and colorectal cancers. It focuses on evaluating the safety and imaging properties of investigational medications in patients with these conditions.
The study evaluates the safety, tolerability, and preliminary effectiveness of the investigational medication. It also looks at how the body processes the medication and how it appears in imaging tests.
- Who can participate: Participants must be 18 years or older with specific advanced or metastatic cancers, including pancreatic, lung, breast, and colorectal cancer.
- Study details: Participants will undergo imaging scans to check eligibility for the investigational medication. The study involves testing different doses to find a recommended dose. A placebo that looks like the investigational medication may be used for comparison.
How understandable was the trial content above?
Hard to understand
Easy to understand